Heterologous prime-boost strategy to immunize very young infants against measles: Pre-clinical studies in rhesus macaques

M. F. Pasetti, A. Resendiz-Albor, K. Ramirez, R. Stout, M. Papania, R. J. Adams, F. P. Polack, B. J. Ward, D. Burt, S. Chabot, J. Ulmer, E. M. Barry, M. M. Levine

Research output: Contribution to journalArticle

Abstract

Infants in developing countries are at high risk of developing severe clinical measles if they become infected during the "window of vulnerability" (age 4-9 months), when declining maternal antibodies do not protect against wild virus, yet impede successful immunization by attenuated measles vaccine. We developed two Sindbis replicon-based DNA vaccines expressing measles virus hemagglutinin and fusion protein with the goal of priming young infants to respond safely and effectively to subsequent boosting with attenuated measles vaccine. Intradermal prime with DNA vaccines by needle-free injection followed by aerosol or parenteral boost with licensed measles vaccine was well tolerated by juvenile and young infant rhesus macaques, and protected against clinical measles and viremia on wild-type virus challenge. A proteosome-measles vaccine administered alone (three doses) or as a boost following DNA vaccine priming was also safe and protective. These promising results pave the way for clinical trials to assess this prime-boost strategy.

Original languageEnglish (US)
Pages (from-to)672-685
Number of pages14
JournalClinical pharmacology and therapeutics
Volume82
Issue number6
DOIs
StatePublished - Dec 1 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Heterologous prime-boost strategy to immunize very young infants against measles: Pre-clinical studies in rhesus macaques'. Together they form a unique fingerprint.

  • Cite this

    Pasetti, M. F., Resendiz-Albor, A., Ramirez, K., Stout, R., Papania, M., Adams, R. J., Polack, F. P., Ward, B. J., Burt, D., Chabot, S., Ulmer, J., Barry, E. M., & Levine, M. M. (2007). Heterologous prime-boost strategy to immunize very young infants against measles: Pre-clinical studies in rhesus macaques. Clinical pharmacology and therapeutics, 82(6), 672-685. https://doi.org/10.1038/sj.clpt.6100420